FABP1 and chronic kidney disease: Similarly, Maeda et al. (2015) showed that L-FABP, as well as urinary albumin-to-creatinine ratio, could be useful in assessing cardiovascular damage in T2D patients at CKD stages 1 and 2, since they correlated with the elevation of cardiac markers and electrocardiogram abnormalities [66].